KAWASAKI DISEASE
Clinical trials for KAWASAKI DISEASE explained in plain language.
Never miss a new study
Get alerted when new KAWASAKI DISEASE trials appear
Sign up with your email to follow new studies for KAWASAKI DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare heart complication: tailored blood thinner under study
Disease control Recruiting nowThis study tests a personalized dose of the blood thinner rivaroxaban in 10 Chinese children who developed giant coronary artery aneurysms (large bulges in heart arteries) after Kawasaki disease. The goal is to see if the dose safely prevents new blood clots and major heart probl…
Matched conditions: KAWASAKI DISEASE
Phase: PHASE4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New study aims to predict treatment failure in kawasaki disease to prevent heart damage
Knowledge-focused Recruiting nowThis study is testing two scoring systems (Kobayashi and Kawanet) to see if they can predict which children with Kawasaki disease will not respond to standard IVIG treatment. The goal is to identify high-risk children early so they can receive stronger initial therapy and avoid h…
Matched conditions: KAWASAKI DISEASE
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
AI tool aims to speed up kawasaki diagnosis in kids
Knowledge-focused Recruiting nowThis study is testing a computer program that helps doctors decide if a child with fever has Kawasaki Disease. About 200 children with fever and signs of Kawasaki will take part. The goal is to see if the tool helps doctors start treatment sooner.
Matched conditions: KAWASAKI DISEASE
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Massive study aims to find safe drug doses for kids
Knowledge-focused Recruiting nowThis study looks at how certain medicines act in the bodies of children and young adults under 21. Researchers want to find the safest and most effective doses for these age groups. Participants are already taking these drugs as part of their regular care, or have had a recent CO…
Matched conditions: KAWASAKI DISEASE
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC